The first in Russia industrial production of components necessary for the creation of mRNA-vaccines against viral, bacterial infections and oncological diseases was launched by the group of companies "Biosan" and "Biolabmix" in Novosibirsk. This reports TASS. Any mRNA can be assembled from these components, and they can be used by scientific teams in Russia, Vladimir Richter, deputy director of Biosan, told journalists.

"We launched Russia's first production of reagents for mRNA vaccines. Packaging with solutions in test tubes, let's call them "cubes". Let's imagine that vaccine or mRNA preparations must be assembled from them. There are many cubes, they are different, each has its own color. There are chemical cubes, there are enzymatic cubes, and there are biotechnological cubes . It is unrealistic to get these cubes quickly, you need a lot of equipment and competence in different areas - chemical synthesis, fermenters for building up enzymes, and chromatographic equipment," Richter said.

He said that the company also produces reagents for molecular biology, genetic engineering, biochemistry and fundamental medicine, which were previously purchased abroad. "Reagents for molecular biology, biochemistry and diagnostics were purchased abroad. We managed to organize the production of some of these components, which are not actually purchased now. In addition, we produce a whole range of PCR kits and here we have managed to significantly squeeze out imported competitors. We can say that Russia has achieved import-independence for these reagents," Richter said.

The number of consumers of Biosan products is counted in hundreds. Among them are leading institutes of the Russian Academy of Sciences, the Russian Ministry of Health, Rospotrebnadzor, FMBA of Russia, as well as development institutes such as Sirius, Skolkovo and Fiztech.